Ovarian Neoplasms: all 2,757 studies
Page 23 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian CancerStatus unknownNCT01650376Phase 1/2
- Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian CancerCompletedNCT01644825Phase 2
- Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian CancerCompletedNCT01639885Phase 1/2
- Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian CancerCompletedNCT01637532Phase 1/2
- Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb TrialCompletedNCT01630018Phase 2
- Phase 3 Trial Evaluating Hyperthermic Intraperitoneal Chemotherapy in Upfront Treatment of Stage IIIC Epithelial Ovarian CancerStatus unknownNCT01628380Phase 3
- Interactive Educational Website for Women With Ovarian Cancer & CaregiversCompletedNCT01626014Early Phase 1
- BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer PatientsWithdrawnNCT01624493Phase 1/2
- Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian CancerCompletedNCT01623349Phase 1
- An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid TumorsCompletedNCT01618136Phase 1/2
- A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian CancerCompletedNCT01616303Phase 2
- Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?Status unknownNCT01611766Phase 3
- Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian CancerCompletedNCT01610869Phase 2
- [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian CancerCompletedNCT01608009Phase 1
- Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian CancerWithdrawnNCT01606358
- Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01606241Phase 1
- Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)Status unknownNCT01600573Phase 1/2
- Validation of a Laparoscopic Score to Predict the Chance of Optimal Cytoreduction in Advanced Ovarian Cancer PatientsCompletedNCT01595204Not applicable
- Structural and Functional Imaging and Cognitive Functions in Ovarian CancerCompletedNCT01591772
- IPHC in Patients With Platinum-sensitive Recurrent Ovarian CancerCompletedNCT01588964Phase 2
- Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of OvaryTerminatedNCT01584297Phase 2
- Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)Status unknownNCT01584115Phase 1/2
- Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian CancerCompletedNCT01583322Phase 2
- Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian CancerCompletedNCT01580696Phase 1/2
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian CancerCompletedNCT01556841Phase 2
- Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive StudyCompletedNCT01544049
- Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer RecurrenceStatus unknownNCT01539785Not applicable
- Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian CancerCompletedNCT01538498
- Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian CancerTerminatedNCT01535157Phase 1/2
- Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological CancersCompletedNCT01523678Phase 2
- Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological PatientsCompletedNCT01523652
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- Intraperitoneal Therapy For Ovarian Cancer With Carboplatin TrialCompletedNCT01506856Phase 2/3
- Diffusion-weighted Imaging Study in Cancer of the OvaryCompletedNCT01505829
- Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT01504126Early Phase 1
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian CancerTerminatedNCT01494012Phase 1
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian CancerTerminatedNCT01493505Phase 3
- Doxorubicin + BIBF 1120 in Patients for Ovarian CancerTerminatedNCT01485874Phase 1
- EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian CancerCompletedNCT01485848Phase 2
- A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian CarcinomaCompletedNCT01481701Phase 2
- A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCompletedNCT01478685Phase 1
- Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic MassWithdrawnNCT01477788
- Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA MutationCompletedNCT01472783Phase 1/2
- Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian CancerCompletedNCT01471483
- Hypodontia and Ovarian CancerStatus unknownNCT01470235
- A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian CancerCompletedNCT01469793Phase 1
- New Biomarkers Evaluating Ovarian CancerCompletedNCT01466049
- Epidemiology of Ovarian Cancer in TaiwanStatus unknownNCT01465750
- Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian CancerCompletedNCT01462890Phase 3
- Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian CancerCompletedNCT01462149Phase 2
- Surgical Complications Related to Primary or Interval Debulking in Ovarian NeoplasmCompletedNCT01461850Phase 3
- Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial CarcinomaCompletedNCT01460979Phase 2
- A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersCompletedNCT01460134Phase 1
- Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
- AZD2281 Plus Carboplatin to Treat Breast and Ovarian CancerCompletedNCT01445418Phase 1
- Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199WithdrawnNCT01445275
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian CancerCompletedNCT01442051Not applicable
- Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian TumorsCompletedNCT01440504
- Juice Plus+ and Juice Plus+ Complete in Ovarian CancerActive, not recruitingNCT01439659Phase 2
- FES-PET to Determine ER-expression in Epithelial Ovarian CancerCompletedNCT01439490Phase 2
- TKM 080301 for Primary or Secondary Liver CancerCompletedNCT01437007Phase 1
- Patient Reported Symptoms in Ovarian Cancer (PRECISION)CompletedNCT01422265
- Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian CancerCompletedNCT01419210Not applicable
- Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
- Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian CancerStatus unknownNCT01388621Phase 2
- Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian CancerStatus unknownNCT01387399Phase 1
- CT-011 and p53 Genetic Vaccine for Advanced Solid TumorsWithdrawnNCT01386502Phase 1
- Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio ImmunotherapyCompletedNCT01384253Phase 1
- An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac SurgeryCompletedNCT01384097
- Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent DetectionTerminatedNCT01383408Phase 2
- INOVATYON STUDY -International, Randomized Study in Patients With Ovarian CancerCompletedNCT01379989Phase 3
- Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African AmericansTerminatedNCT01374685
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal CancerStatus unknownNCT01372787
- Characterization of Ovarian Cancer Stem CellStatus unknownNCT01367353Not applicable
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerStatus unknownNCT01366183
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney DysfunctionActive, not recruitingNCT01366144Phase 1
- Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian CancerCompletedNCT01363947Phase 1
- Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian CancerCompletedNCT01358071Phase 2
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
- Study of Circulating Tumoral DNA in Ovarian CancerCompletedNCT01350908Not applicable
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic CancerCompletedNCT01335958Phase 1
- Blood Test for Ovarian Cancer Associated Auto AntibodiesStatus unknownNCT01334437
- Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer PatientsTerminatedNCT01334047Phase 1/2
- Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian CancerCompletedNCT01333748Phase 2
- Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/PaclitaxelCompletedNCT01332656Phase 2
- Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian CancerCompletedNCT01322802Phase 1
- Therapeutic Targeting of Stress Factors in Ovarian Cancer PatientsCompletedNCT01308944Phase 1
- French Observatory of Rare Malignant Tumors of the OvaryCompletedNCT01304043
- TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity CancerCompletedNCT01294293Phase 1
- Cancer Screening Program for Women at High Risk for Developing Ovarian CancerTerminatedNCT01292733Early Phase 1
- AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)TerminatedNCT01281254Phase 3
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian CancerTerminatedNCT01279291Phase 1
- Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CTActive, not recruitingNCT01276574
- A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian CancerCompletedNCT01276548Phase 2
- Endoxifen in Adults With Hormone Receptor Positive Solid TumorsCompletedNCT01273168Phase 1
- Circulating Lymphatic Progenitor Cell and Lymph Node MetastasisStatus unknownNCT01268956
- Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian CancerCompletedNCT01262014Phase 2
- Retrospective Study of Ovarian Cancer Patients With Brain MetastasisStatus unknownNCT01258881
- Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and SolidsCompletedNCT01256268Phase 1